📰 Will Evaluate News
Will Evaluate News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Will Evaluate. Real-time updates on events, politics, business and more.
July 6, 2023
Randomized Phase 3 Trial (RAMP 301) Will Evaluate the Combination of Avutometinib and Defactinib vs Standard of Care Treatment; Study to Commence in 2H 2023Recently Published Data from Part A of RAMP 201 Trial Show an Objective Response Rate of 45%, and Manageable Safety and Tolerability Profile with the Combination...
May 17, 2023
IND Clearance for a New Class of Therapeutic Prenylated Phenolic FlavonePhase I Clinical Trial Expected to Launch in 2023 and Will Evaluate the Safety and Preliminary Antitumor Activity of Caflanone in
July 14, 2022
/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), today announced that it has received clearance of its Investigational New Drug (IND)...